サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：前臨床イメージングの世界市場：2023-2030年
市場調査レポート
商品コード
1380448

前臨床イメージングの世界市場：2023-2030年

Global Preclinical Imaging Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 200 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
前臨床イメージングの世界市場：2023-2030年
出版日: 2023年10月01日
発行: Orion Market Research
ページ情報: 英文 200 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の前臨床イメージング市場は、予測期間（2023-2030年）にCAGR 6.82％で成長すると予測されています。市場の成長は、感度と解像度の向上に起因しています。高磁場MRIシステムはスキャンの感度と解像度を向上させ、研究者が動物モデルの繊細な構造的・機能的変化を検出・分析することを可能にします。この高い感度と解像度は、疾患の正確なモデル化や潜在的な薬剤候補の評価に重要です。それに伴い、市場各社は新しいMRI装置の需要に応えるべく新製品を発表しています。例えば、2022年5月、ブルカーは、市場をリードする前臨床MRIシステムの製品ラインの構成要素として、7.4テスラと9.4テスラの伝導冷却マックスウェル磁石を含む革新的な磁気共鳴イメージング（MRI）装置を発売しました。BioSpec Maxwell 3テスラ・モデルは大成功を収め、Liquidは新世代のMaxwell 7.4テスラおよび9.4テスラ・マグネットのおかげで必要不可欠なものとなりつつあります。

セグメント別の展望

超音波イメージングサブセグメントが世界の前臨床イメージング市場でかなりのシェアを占めると予想される

製品別では、超音波イメージングサブセグメントが世界の前臨床イメージング市場でかなりのシェアを占めると予想されています。このセグメントの成長は、技術革新によるものです。超音波・光音響イメージングのようなイメージング技術の進歩により、研究者が新たな前臨床研究の方向性を探ることができるようになり、利用が増加しています。それに伴い、市場各社は前臨床用に設計された超音波・光音響イメージングシステムの需要に応える新製品を発表しています。例えば、富士フイルムビジュアルソニックスは2022年5月、世界初の前臨床用超高周波から低周波（71MHz-1MHz）超音波・光音響イメージングシステムであるVevo F2を発売しました。Vevo F2は、トランスデューサからディスプレイ画面まで、新しい信号パイプライン全体を生成し、HD画像処理技術を搭載しています。マルチライン処理との組み合わせにより、画像の鮮明度が向上し、前世代のプラットフォームよりもフレームレートが大幅に向上しています。

地域別展望

世界の前臨床イメージング市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されています。なかでもアジア太平洋地域は、各国の研究開発部門の成長に対する政府支援の増加により、前臨床研究にとってますます望ましい地域となっているため、世界全体で大きなシェアを占めると予想されます。

北米地域は世界の前臨床イメージング市場において著しいCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。同地域の成長は、同地域におけるヘルスケアの拡大に起因しています。高度なイメージング技術、特に前臨床イメージングに対する世界の需要は、ヘルスケアサービスの成長に伴って増加すると予測されています。米国労働統計局の2023年9月の発表によると、放射線技師とMRI技師の総雇用は2022年から2032年の間に6％増加し、全職種の平均を上回ると予測されています。今後10年間で、放射線技師とMRI技師の募集は平均15,700件あると予想されます。転職や定年退職による離職者の補充が必要なため、求人数の大部分を占めると予測されます。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Advanced Molecular Vision, Inc
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Aspect Imaging Ltd.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • AXT PTY LTD.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 前臨床イメージングの世界市場：製品別
    • MicroCT（マイクロCT）
    • MRI（磁気共鳴画像法）
    • PET（ポジトロン断層法）
    • 超音波イメージング
    • 光学イメージング
    • 光音響イメージング
    • その他（放射性医薬品とトレーサー、赤外線イメージング）
  • 前臨床イメージングの世界市場：用途別
    • 研究開発
    • 神経学・神経科学
    • その他（毒性学と安全性評価、遺伝子治療と分子イメージング、精密医療と個別化治療）
  • 前臨床イメージングの世界市場：エンドユーザー別
    • 製薬企業およびバイオテクノロジー企業
    • 学術・研究機関
    • 病院および医療センター
    • 政府研究機関
    • その他（薬理学および毒物学研究所、規制機関および当局）

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Bruker Corp.
  • Euro-BioImaging ERIC
  • FUJIFILM Holdings Corp.
  • IVIM Technology Corp.
  • Mediso Kft.
  • MR Solutions Ltd.
  • Oxford Nanoimaging Ltd.
  • PerkinElmer AES
  • Photon Etc. Inc
  • Revvity, Inc.
  • Shanghai United Imaging Healthcare Co., LTD.
図表

LIST OF TABLES

  • 1. GLOBAL PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL MICROCT PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL MRI PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PET PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL ULTRASOUND PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL PHOTOACOUSTIC PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL OTHER PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION)
  • 10. GLOBAL PRECLINICAL IMAGING IN RESEARCH AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL PRECLINICAL IMAGING IN NEUROLOGY AND NEUROSCIENCE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL PRECLINICAL IMAGING IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 14. GLOBAL PRECLINICAL IMAGING FOR PHARMA AND BIOTECH COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL PRECLINICAL IMAGING FOR ACADEMIC AND RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL PRECLINICAL IMAGING FOR HOSPITALS AND MEDICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL PRECLINICAL IMAGING FOR GOVERNMENT RESEARCH AGENCIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. GLOBAL PRECLINICAL IMAGING FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. GLOBAL PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY PRODUCT , 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 24. EUROPEAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. EUROPEAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 26. EUROPEAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 27. EUROPEAN PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 28. ASIA- PACIFIC PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 29. ASIA- PACIFIC PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 30. ASIA- PACIFIC PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 31. ASIA- PACIFIC PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 33. REST OF THE WORLD PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 35. REST OF THE WORLD PRECLINICAL IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PRECLINICAL IMAGING MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL MICROCT PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL MRI PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PET PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL ULTRASOUND PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL OPTICAL PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL PHOTOACOUSTIC PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL OTHERS PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL PRECLINICAL IMAGING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 10. GLOBAL PRECLINICAL IMAGING IN RESEARCH AND DEVELOPMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL PRECLINICAL IMAGING IN NEUROLOGY AND NEUROSCIENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL PRECLINICAL IMAGING IN OTHERS MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 13. GLOBAL PRECLINICAL IMAGING MARKET FOR ESEARCH AND ANALYSIS BY END-USER, 2022 VS 2030 (%)
  • 14. GLOBAL PRECLINICAL IMAGING FOR PHARMA AND BIOTECH COMPANIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL PRECLINICAL IMAGING FOR ACADEMIC AND RESEARCH INSTITUTIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL PRECLINICAL IMAGING FOR NEUROLOGY AND NEUROSCIENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL PRECLINICAL IMAGING FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL PRECLINICAL IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 19. US PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CANADA PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. UK PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. FRANCE PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. GERMANY PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. ITALY PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SPAIN PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF EUROPE PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. INDIA PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. CHINA PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. JAPAN PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. REST OF ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD PRECLINICAL IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027737

Title: Global Preclinical Imaging Market Size, Share & Trends Analysis Report by Product (MicroCT (Micro Computed Tomography), MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), Ultrasound Imaging, Optical Imaging, Photoacoustic Imaging, and Others), by Application (Pharma and Biotech Companies, Research and Development, Neurology and Neuroscience, and Others), and by End-User (Pharma and Biotech Companies, Academic and Research Institutions, Hospitals and Medical Centers, Government Research Agencies, and Others)Forecast Period (2023-2030).

The global preclinical imaging market is anticipated to grow at a CAGR of 6.82% during the Forecast Period (2023-2030). The market's growth is attributed to enhancement of sensitivity and resolution. High-field MRI systems improve the sensitivity and resolution of scans, enabling researchers to detect and analyze delicate structural and functional modifications in animal models. This higher level of sensitivity and resolution is important for accurately modeling diseases and evaluating potential drug candidates. Accordingly market players are coming up with new products to cater the demand for new MRI devices. For instance, in May 2022,Bruker launched innovative magnetic resonance imaging (MRI) devices, including 7.4 Tesla and 9.4 Tesla conduction-cooled Maxwell magnets, form a component of its product line of market-leading preclinical MRI systems. The BioSpec Maxwell 3 Tesla model was an enormous success, and the Liquid is ceased to essential owing to a new generation of Maxwell 7.4 Tesla and 9.4 Tesla magnets. while providing high-field sensitivity and nitrogen or helium refills resolution for innovative PET/MR and MRI preclinical research.

Segmental Outlook

The global preclinical imaging market is segmented on the product, application, and end-user. Based on the product, the market is sub-segmented into MicroCT, MRI, PET, ultrasound imaging, optical imaging, photoacoustic imaging, and others. Based on the application, the market is sub-segmented into pharma and biotech companies, research and development, neurology and neuroscience, and others. Furthermore, on the basis of end-user, the market is sub-segmented into pharma and biotech companies, academic and research institutions, hospitals and medical centers, government research agencies, and others. The pharma and biotech company's subcategory is expected to capture a significant portion of the market share within the end-user segment. This is attributed to the development and reemergence of infectious diseases, the demand for preclinical imaging for enhanced comprehension of pathogens and encourage the creation of innovative therapies and vaccines.

The Ultrasound Imaging Sub-Segment is Anticipated to Hold a Considerable Share of the Global Preclinical Imaging Market

Among the product, the ultrasound imaging sub-segment is expected to hold a considerable share of the global preclinical imaging market. The segmental growth is attributed to the innovation in technology. Increased usage results from the ability of researchers to explore new preclinical research directions owing to advancements in imaging technologies such as ultrasound and photoacoustic imaging. Accordingly market players are coming up with new products to cater the demand for ultrasound and photoacoustic imaging system designed for preclinical use. For instance, in May 2022,FUJIFILM VisualSonics Inc., launched Vevo F2, the globe's first ultra-high to low frequency (71MHz-1MHz) ultrasound and photoacoustic imaging system for preclinical use. The Vevo F2 produces entire new signal pipeline, from transducer to display screen, and includes HD image processing technologies. In combination with multi-line processing, it improves image clarity and results in significantly higher frame rates than platforms from preceding generations.

Regional Outlook

The global preclinical imaging market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, as the region has grown increasingly desirable for preclinical research studies owing to increased government support for the growth of the research and development sector in the individual countries.

The North America Region is Expected to Grow at a Significant CAGR in the Global Preclinical Imaging Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the expansion of healthcare in the region. Global demand for advanced imaging technologies, especially preclinical imaging, is anticipated to increase as healthcare services grow. According to the US Bureau of Labor Statistics, in September 2023, Radiologic and MRI technologists' total employment is anticipated to increase by 6% between 2022 and 2032, faster than the average for all occupations. Over the next ten years, there are anticipated to be, on average, 15,700 openings for radiologic and MRI technologists. The need to replace workers that change careers or leave the workforce owing to retirement is predicted to cause a large portion of the available openings.

Market Players Outlook

The major companies serving the global preclinical imaging market include: Bruker Corp., Euro-BioImaging ERIC, FUJIFILM Holdings Corp., IVIM Technology Corp., Mediso Kft. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2019, Bruker collaborated to develop the first 18 Tesla, 11 cm bore, preclinical ultra-high field (UHF) MRI machine constantly.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global preclinical imaging market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Advanced Molecular Vision, Inc
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Aspect Imaging Ltd.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. AXT PTY LTD.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Preclinical Imaging Market by Product
    • 4.1.1. MicroCT (Micro Computed Tomography)
    • 4.1.2. MRI (Magnetic Resonance Imaging)
    • 4.1.3. PET (Positron Emission Tomography)
    • 4.1.4. Ultrasound Imaging
    • 4.1.5. Optical Imaging
    • 4.1.6. Photoacoustic Imaging
    • 4.1.7. Others ( Radiopharmaceuticals and Tracers, and Infrared Imaging )
  • 4.2. Global Preclinical Imaging Market by Application
    • 4.2.1. Research and Development
    • 4.2.2. Neurology and Neuroscience
    • 4.2.3. Others (Toxicology and Safety Assessment, Gene Therapy and Molecular Imaging, and Precision Medicine, and Personalized Therapies)
  • 4.3. Global Preclinical Imaging Market by End-User
    • 4.3.1. Pharma and Biotech Companies
    • 4.3.2. Academic and Research Institutions
    • 4.3.3. Hospitals and Medical Centers
    • 4.3.4. Government Research Agencies
    • 4.3.5. Others (Pharmacology and Toxicology Laboratories, and Regulatory Bodies & Authorities)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Bruker Corp.
  • 6.2. Euro-BioImaging ERIC
  • 6.3. FUJIFILM Holdings Corp.
  • 6.4. IVIM Technology Corp.
  • 6.5. Mediso Kft.
  • 6.6. MR Solutions Ltd.
  • 6.7. Oxford Nanoimaging Ltd.
  • 6.8. PerkinElmer AES
  • 6.9. Photon Etc. Inc
  • 6.10. Revvity, Inc.
  • 6.11. Shanghai United Imaging Healthcare Co., LTD.